aDepartment of Medical Oncology, The Kinghorn Cancer Centre, St. Vincent’s Hospital Sydney
bSchool of Clinical Medicine, UNSW Medicine and Health, St Vincent’s Hospital, Darlinghurst
cDepartment of Ophthalmology, Sydney Eye Hospital, Sydney, NSW, Australia
dDepartment of Medical Oncology, PSL Research University, Institut Curie, Paris, France
eDepartment of Medical Oncology, NHMRC Clinical Trials Centre, University of Sydney, Camperdown and
fMelanoma Institute Australia, University of Sydney, North Sydney, NSW, Australia
Received 16 February 2023 Accepted 17 April 2023.
Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.melanomaresearch.com.
Correspondence to Dr James P. Pham, MD, Department of Medical Oncology, The Kinghorn Cancer Centre, St Vincent’s Hospital Sydney, 370 Victoria St, Darlinghurst, NSW, Australia, Tel: +02 9355 5655; e-mail: [email protected]
